Home | About CytoJournalEditorial Board | Archived articles | Search CytoJ Articles | Subscribe | Peer review policies | CytoJournal Quiz Cases
  Reviewer corner | Author corner | OA Steward’s corner | CF member’s corner | Join as CF member | Manuscript submission | Open Access (OA) Advocacy
Home
CytoJournal All 'FULL TEXT' in HTML are FREE under "open access" charter of CytoJournal.
To login for downloading any PDF OR to request TOC (Table of Content) by e-mail, please click here
Home Email this page Print this page Small font size Default font size Increase font size Cytopathology Foundation
Read this article

 


    Article Cited by others

RESEARCH

Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules

Rowe Leslie R, Bentz Brandon G, Bentz Joel S

Year : 2006| Volume: 3| Issue : 1 | Page no: 10-10

   This article has been cited by
 
1 BRAF mutation in fine-needle aspiration specimens as a potential predictor for persistence/recurrence in patients with classical papillary thyroid carcinoma larger than 10 mm at a BRAF mutation prevalent area
Hee Jung Moon,Eun-Kyung Kim,Woong Youn Chung,Dong Yeob Shin,Jin Young Kwak
Head & Neck. 2015; : n/a
[Pubmed]  [Google Scholar] [DOI]
2 Utility ofBRAFmutation detection in fine-needle aspiration biopsy samples read as “suspicious for papillary thyroid carcinoma”
Sebastian M. Jara,Ramneesh Bhatnagar,Hui Guan,Christopher D. Gocke,Syed Z. Ali,Ralph P. Tufano
Head & Neck. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
3 Best practice of BRAF V600E mutation testing for the diagnosis and management of thyroid cancers
Adebowale J Adeniran,Pei Hui
Expert Review of Endocrinology & Metabolism. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]
4 BRAF gene: From human cancers to developmental syndromes
Muhammad Ramzan Manwar Hussain,Mukhtiar Baig,Hussein Sheik Ali Mohmoud,Zaheer Ulhaq,Daniel Hosseli,Ghaidaa Siraj Khogeer,Ranem Radwan Al-sayed,Jumana Yousuf Al-Aama
Saudi Journal of Biological Sciences. 2014;
[Pubmed]  [Google Scholar] [DOI]
5 Serum Thyroglobulin Adds No Additional Value to Ultrasonographic Features in a Thyroid Malignancy
Inyoung Youn,Ji Min Sung,Eun-Kyung Kim,Jin Young Kwak
Ultrasound Quarterly. 2014; 30(4): 287
[Pubmed]  [Google Scholar] [DOI]
6 Guidelines for the management of thyroid cancer
Petros Perros,Kristien Boelaert,Steve Colley,Carol Evans,Rhodri M Evans,Georgina Gerrard BA,Jackie Gilbert,Barney Harrison,Sarah J Johnson,Thomas E Giles,Laura Moss,Val Lewington,Kate Newbold,Judith Taylor,Rajesh V Thakker,John Watkinson,Graham R. Williams
Clinical Endocrinology. 2014; 81: 1
[Pubmed]  [Google Scholar] [DOI]
7 BRAF V600 co-testing in thyroid FNA cytology: short-term experience in a large cancer centre in the UK
D. N. Poller,S. Glaysher,A. Agrawal,S. Caldera,D. Kim,C. Yiangou
Journal of Clinical Pathology. 2014; 67(8): 684
[Pubmed]  [Google Scholar] [DOI]
8 An Update On Molecular Biology Of Thyroid Cancers
Ozgur Omur,Yusuf Baran
Critical Reviews in Oncology/Hematology. 2013;
[Pubmed]  [Google Scholar] [DOI]
9 RAF-targeted therapy for hepatocellular carcinoma in the regenerating liver
Ji-Hua Shi,Shu-Zheng Liu,Lene Wierød,Hanne Scholz,Jarl Andreas Anmarkrud,Henrik S. Huitfeldt,Shui-Jun Zhang,Pål-Dag Line
Journal of Surgical Oncology. 2013; 107(4): 393
[Pubmed]  [Google Scholar] [DOI]
10 Pilocytic astrocytomas of the optic nerve and their relation to pilocytic astrocytomas elsewhere in the central nervous system
Gerald F Reis,Michele M Bloomer,Arie Perry,Joanna J Phillips,James P Grenert,Anthony N Karnezis,Tarik Tihan
Modern Pathology. 2013; 26(10): 1279
[Pubmed]  [Google Scholar] [DOI]
11 RAF-targeted therapy for hepatocellular carcinoma in the regenerating liver
Shi, J.-H. and Liu, S.-Z. and Wierød, L. and Scholz, H. and Anmarkrud, J.A. and Huitfeldt, H.S. and Zhang, S.-J. and Line, P.-D.
Journal of Surgical Oncology. 2013; 107(4): 393-401
[Pubmed]  [Google Scholar]
12 Assessment of cellularity, genomic DNA yields, and technical platforms forBRAFmutational testing in thyroid fine-needle aspirate samples
Kathryn Dyhdalo,Stephen MacNamara,Jennifer Brainard,Dawn Underwood,Raymond Tubbs,Bin Yang
Cancer Cytopathology. 2013; : n/a
[Pubmed]  [Google Scholar] [DOI]
13 Applications and limitations of oncogene mutation testings in clinical cytopathology
C. Bellevicine,G. Vita,U. Malapelle,G. Troncone
Seminars in Diagnostic Pathology. 2013;
[Pubmed]  [Google Scholar] [DOI]
14 Is Follow-up BRAFV600E Mutation Analysis Helpful in the Differential Diagnosis of Thyroid Nodules with Negative Results on Initial Analysis?
Yoon, J.H. and Kim, E.-K. and Moon, H.J. and Kwak, J.Y.
PLoS ONE. 2013; 8(3)
[Pubmed]  [Google Scholar]
15 Contribution of the BRAF oncogene in the pre-operative phase of thyroid carcinoma
Correia Rodrigues, H.G. and De Pontes, A.A.N. and Fernando Adan, L.
Oncology Letters. 2013; 6(1): 191-196
[Pubmed]  [Google Scholar]
16 Impact of different methodologies on the detection of point mutations in routine air-dried fine needle aspiration (FNA) smears
Rehfeld, C. and Münz, S. and Krogdahl, A. and Jensen, E.M.P. and Siebolts, U. and Ferraz, C. and Bösenberg, E. and Hegedüs, L. and Paschke, R. and Eszlinger, M.
Hormone and Metabolic Research. 2013; 45(7): 513-517
[Pubmed]  [Google Scholar]
17 Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAFT1799A mutation on fine-needle aspiration biopsy specimens: A prospective study of 814 thyroid FNAB patients
Cañadas-Garre, M. and Becerra-Massare, P. and De La Torre-Casares, M.L. and Villar-Del Moral, J. and Céspedes-Mas, S. and Vílchez-Joya, R. and Muros-De Fuentes, T. and García-Calvente, C. and Piédrola-Maroto, G. and López-Nevot, M.A. and Montes-Ramírez, R. and Llamas-Elvira, J.M.
Annals of Surgery. 2012; 255(5): 986-992
[Pubmed]  [Google Scholar]
18 BRAF mutation testing in clinical practice
Ziai, J. and Hui, P.
Expert Review of Molecular Diagnostics. 2012; 12(2): 127-138
[Pubmed]  [Google Scholar]
19 BRAF mutations in papillary thyroid carcinoma and emerging targeted therapies (Review)
Leonardi, G.C. and Candido, S. and Carbone, M. and Raiti, F. and Colaianni, V. and Garozzo, S. and Cinà, D. and McCubrey, J.A. and Libra, M.
Molecular Medicine Reports. 2012; 6(4): 687-694
[Pubmed]  [Google Scholar]
20 BRAFV600E mutation testing in fine needle aspirates of thyroid nodules: Potential value of real-time PCR
Kwak, J.Y. and Han, K.H. and Yoon, J.H. and Kim, E.-K. and Moon, H.J. and Kim, Y.-L. and Park, S.-J. and Choi, J.R.
Annals of Clinical and Laboratory Science. 2012; 42(3): 258-265
[Pubmed]  [Google Scholar]
21 BRAFV600E mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness
Neslihan Kurtulmus, Mete Duren, Umit Ince, M. Cengiz Yakicier, Onder Peker, Ozlem Aydın, Ender Altiok, Serdar Giray, Halil Azizlerli
Endocrine. 2012;
[HTML Full text]  [Google Scholar] [DOI]
22 <i>BRAF</i> mutation testing in clinical practice
James Ziai, Pei Hui
Expert Review of Molecular Diagnostics. 2012; 12(2): 127
[HTML Full text]  [Google Scholar] [DOI]
23 Reduction of False-Negative Papillary Thyroid Carcinomas by the Routine Analysis of BRAFT1799A Mutation on Fine-Needle Aspiration Biopsy Specimens : A Prospective Study of 814 Thyroid FNAB Patients
Annals of Surgery. 2012; 255(5): 986
[HTML Full text]  [Google Scholar] [DOI]
24 Factors influencing the detection of the BRAF T1799A mutation in papillary thyroid carcinoma
Kim, H.S., Kim, J.O., Lee, D.H., Lee, H.C., Kim, H.J., Kim, J.H., Jang, Y.S., (...), Kim, Y.S.
Oncology Reports. 2011; 25(6): 1639-1644
[Pubmed]  [Google Scholar]
25 Reflex BRAF Testing in Thyroid Fine-Needle Aspiration Biopsy with Equivocal and Positive Interpretation: A Prospective Study
Adebowale J. Adeniran, Constantine Theoharis, Pei Hui, Manju L. Prasad, Lynwood Hammers, Tobias Carling, Robert Udelsman, David C. Chhieng
Thyroid. 2011; 21(7): 717
[HTML Full text]  [Google Scholar] [DOI]
26 Molecular analysis of thyroid tumors
Yuri E Nikiforov
Modern Pathology. 2011; 24: S34
[HTML Full text]  [Google Scholar] [DOI]
27 Allele-specific PCR with competitive probe blocking for sensitive and specific detection of BRAF V600E in thyroid fine-needle aspiration specimens
Smith, G.D. and Zhou, L. and Rowe, L.R. and Jarboe, E.A. and Collins, B.T. and Bentz, J.S. and Wittwer, C.T. and Chadwick, B.E.
Acta Cytologica. 2011; 55(6): 576-583
[Pubmed]  [Google Scholar]
28 BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance
Adeniran, A.J. and Hui, P. and Chhieng, D.C. and Prasad, M.L. and Schofield, K. and Theoharis, C.
Acta Cytologica. 2011; 55(6): 570-575
[Pubmed]  [Google Scholar]
29 BRAF gene mutation in the natural history of papillary thyroid carcinoma: Diagnostic and prognostic implications [Mutação do gene BRAF na história natural do carcinoma papilar da tireóide: Implicações diagnósticas e prognósticas]
Lopes, J.P. and Fonseca, E.
Acta Medica Portuguesa. 2011; 24(SUPPL.4): 855-868
[Pubmed]  [Google Scholar]
30 Risk stratification of indeterminate thyroid fine-needle aspiration biopsy specimens based on mutation analysis
Filicori, F. and Keutgen, X.M. and Buitrago, D. and Aldailami, H. and Crowley, M. and Fahey, T.J. and Zarnegar, R.
Surgery. 2011; 150(6): 1085-1091
[Pubmed]  [Google Scholar]
31 Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules
Ferraz, C. and Eszlinger, M. and Paschke, R.
Journal of Clinical Endocrinology and Metabolism. 2011; 96(7): 2016-2026
[Pubmed]  [Google Scholar]
32 McGill Thyroid Nodule Score (MTNS): "Rating the risk," a novel predictive scheme for cancer risk determination
Sands, N.B. and Karls, S. and Amir, A. and Tamilia, M. and Gologan, O. and Rochon, L. and Black, M.J. and Hier, M.P. and Payne, R.J.
Journal of Otolaryngology - Head and Neck Surgery. 2011; 40(SUPPL. 1): S1-S13
[Pubmed]  [Google Scholar]
33 BRAF V600E mutation in papillary thyroid carcinoma: Prevalence and detection in fine needle aspiration specimens [Mutation BRAF V600E et carcinomes papillaires de la thyroïde: Prévalence et faisabilité de la détection sur produits de cytoponction]
Dujardin, F. and Pagès, J.-C. and Collin, C. and de Calan, L. and Lecomte, P. and Guyétant, S.
Annales de Pathologie. 2010; 30(4): 252-262
[Pubmed]  [Google Scholar]
34 Clinical impact of the detection of BRAF mutations in thyroid pathology: Potential usefulness as diagnostic, prognostic and theragnostic applications
Lassalle, S. and Hofman, V. and Ilie, M. and Butori, C. and Bozec, A. and Santini, J. and Vielh, P. and Hofman, P.
Current Medicinal Chemistry. 2010; 17(17): 1839-1850
[Pubmed]  [Google Scholar]
35 Follicular variant of papillary carcinoma: Reproducibility of histologic diagnosis and utility of HBME-1 immunohistochemistry and braf mutational analysis as diagnostic adjuncts
Wallander, M. and Layfield, L.J. and Jarboe, E. and Emerson, L. and Liu, T. and Thaker, H. and Holden, J. and Tripp, S.
Applied Immunohistochemistry and Molecular Morphology. 2010; 18(3): 231-235
[Pubmed]  [Google Scholar]
36 Galectin-3 expression and BRAF mutation in cases of cytologically suspicious papillary thyroid carcinoma
Kim, D. and Kim, H. and Kwak, J. and Kim, M. and Jung, H.J. and Koo, J.S. and Lim, B.J. and Jung, C. and Hong, S.W.
Korean Journal of Pathology. 2010; 44(2): 191-198
[Pubmed]  [Google Scholar]
37 The biology of thyroid oncogenesis
Kebebew, E. and Suh, I.
Cancer Treatment and Research. 2010; 153: 3-21
[Pubmed]  [Google Scholar]
38 Dual priming oligonucleotide-based multiplex PCR analysis for detection of BRAFV600E mutation in FNAB samples of thyroid nodules in BRAF V600E mutation-prevalent area
Kwak, J.Y., Kim, E.-K., Kim, J.-K., Han, J.-H., Hong, S.W., Park, T.S., Choi, J.R.
Head and Neck. 2010; 32(4): 490-498
[Pubmed]  [Google Scholar]
39 Clinical implications of molecular studies for the diagnosis of thyroid cancer
Eszlinger, M., Schmid, K.W., Paschke, R.
Hormones. 2010; 9(1): 51-56
[Pubmed]  [Google Scholar]
40 Enrichment and detection of rare alleles by means of snapback primers and rapid-cycle PCR
Zhou, L., Palais, R.A., Denice Smith, G., Anderson, D., Rowe, L.R., Wittwer, C.T.
Clinical Chemistry. 2010; 56(5): 814-822
[Pubmed]  [Google Scholar]
41 Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns
Eszlinger, M., Paschke, R.
Molecular and Cellular Endocrinology. 2010; 322(1-2): 29-37
[Pubmed]  [Google Scholar]
42 Surgical implications of B-RafV600E mutation in fine-needle aspiration of thyroid nodules
Michal Mekel,Carmelo Nucera,Richard A. Hodin,Sareh Parangi
The American Journal of Surgery. 2010; 200(1): 136
[Pubmed]  [Google Scholar] [DOI]
43 Galectin-3 Expression and BRAF Mutation in Cases of Cytologically Suspicious Papillary Thyroid Carcinoma
Dokyung Kim,Hyunki Kim,Jinyoung Kwak,Minju Kim,Hyung Jae Jung,Ja Seung Koo,Beom Jin Lim,Chankwon Jung,SoonWon Hong
The Korean Journal of Pathology. 2010; 44(2): 191
[Pubmed]  [Google Scholar] [DOI]
44 Mutation BRAF V600E et carcinomes papillaires de la thyroïde : prévalence et faisabilité de la détection sur produits de cytoponction
Fanny Dujardin,Jean-Christophe Pagès,Christine Collin,Loïc de Calan,Pierre Lecomte,Serge Guyétant
Annales de Pathologie. 2010; 30(4): 252
[Pubmed]  [Google Scholar] [DOI]
45 BRAF mutations in papillary thyroid carcinoma: Diagnostic role, prognostic implications, and a guide for clinical management
Bansal, M. and Nikiforov, Y.E.
Pathology Case Reviews. 2010; 15(4): 121-125
[Pubmed]  [Google Scholar]
46 The BRAF Mutation Is Predictive of Aggressive Clinicopathological Characteristics in Papillary Thyroid Microcarcinoma
Kuai-Lu Lin, Ou-Chen Wang, Xiao-Hua Zhang, Xuan-Xuan Dai, Xiao-Qu Hu, Jin-Miao Qu
Annals of Surgical Oncology. 2010; 17(12): 3294
[HTML Full text]  [Google Scholar] [DOI]
47 The utility of BRAF testing in the management of papillary thyroid cancer
Melck, A.L., Yip, L., Carty, S.E.
Oncologist. 2010; 15(12): 1285-1293
[Pubmed]  [Google Scholar]
48 BRAF V600E mutation in papillary thyroid carcinoma: Prevalence and detection in fine needle aspiration specimens | [Mutation BRAF V600E et carcinomes papillaires de la thyroïde: Prévalence et faisabilité de la détection sur produits de cytoponction]
Dujardin, F., Pagès, J.-C., Collin, C., de Calan, L., Lecomte, P., Guyétant, S.
Annales de Pathologie. 2010; 30(4): 252-262
[Pubmed]  [Google Scholar]
49 Surgical implications of B-RafV600E mutation in fine-needle aspiration of thyroid nodules
Mekel, M., Nucera, C., Hodin, R.A., Parangi, S.
American Journal of Surgery. 2010; 200(1): 136-143
[Pubmed]  [Google Scholar]
50 Molecular Testing for Somatic Mutations Improves the Accuracy of Thyroid Fine-needle Aspiration Biopsy
Willieford Moses, Julie Weng, Ileana Sansano, Miao Peng, Elham Khanafshar, Britt-Marie Ljung, Quan-Yang Duh, Orlo H. Clark, Electron Kebebew
World Journal of Surgery. 2010; 34(11): 2589
[HTML Full text]  [Google Scholar] [DOI]
51 BRAF Mutations in Papillary Thyroid Carcinoma : Diagnostic Role, Prognostic Implications, and a Guide for Clinical Management
Mona Bansal, Yuri E. Nikiforov
Pathology Case Reviews. 2010; 15(4): 121
[HTML Full text]  [Google Scholar] [DOI]
52 Follicular Variant of Papillary Carcinoma: Reproducibility of Histologic Diagnosis and Utility of HBME-1 Immunohistochemistry and BRAF Mutational Analysis as Diagnostic Adjuncts :
Michelle Wallander, Lester J. Layfield, Elke Jarboe, Lyska Emerson, Ting Liu, Harshwardhan Thaker, Joseph Holden, Sheryl Tripp
Applied Immunohistochemistry & Molecular Morphology. 2010; 18(3): 231-235
[Pubmed]  [Google Scholar] [DOI]
53 Prevalence of BRAFV600E Mutation in Iranian Patients with Papillary Thyroid Carcinoma: A Single-Center Study
J. Mohammadi-, B. Larijani, Z. Khorgami, S.M. Tavangar, V. Haghpanah, P. Mehdipour
Journal of Applied Sciences. 2009; 9(19): 3593-3597
[Pubmed]  [Google Scholar] [DOI]
54 Molecular Diagnostics and Predictors in Thyroid Cancer
Marina N. Nikiforova, Yuri E. Nikiforov
Thyroid. 2009; 19(12): 1351
[HTML Full text]  [Google Scholar] [DOI]
55 B-RAF V600E mutational analysis of fine needle aspirates correlates with diagnosis of thyroid nodules
Bentz, B.G. and Miller, B.T. and Holden, J.A. and Rowe, L.R. and Bentz, J.S.
Otolaryngology-Head and Neck Surgery. 2009; 140(5): 709-714
[Pubmed]  [Google Scholar]
56 Molecular Markers in Thyroid Cancer Diagnostics
Meredith A. Kato,Thomas J. Fahey
Surgical Clinics of North America. 2009; 89(5): 1139
[Pubmed]  [Google Scholar] [DOI]
57 Dual priming oligonucleotide-based multiplex PCR analysis for detection of BRAFV600Emutation in FNAB samples of thyroid nodules in BRAFV600Emutation-prevalent area
Jin Young Kwak,Eun-Kyung Kim,Jong-Kee Kim,Jeong-Hyun Han,Soon Won Hong,Tae Sung Park,Jong Rak Choi
Head & Neck. 2009; : NA
[Pubmed]  [Google Scholar] [DOI]
58 Molecular Markers in Thyroid Cancer Diagnostics
Kato, M.A., Fahey III, T.J.
Surgical Clinics of North America. 2009; 89(5): 1139-1155
[Pubmed]  [Google Scholar]
59 Prevalence of BRAFV600E mutation in Iranian patients with papillary thyroid carcinoma: A single-center study
Mohammadi-Asl, J. and Larijani, B. and Khorgami, Z. and Tavangar, S.M. and Haghpanah, V. and Mehdipour, P.
Journal of Applied Sciences. 2009; 9(19): 3593-3597
[Pubmed]  [Google Scholar]
60 Update on the molecular diagnosis of endocrine tumors: Toward -omics-based personalized healthcare?
Weber, F. and Eng, C.
Journal of Clinical Endocrinology and Metabolism. 2008; 93(4): 1097-1104
[Pubmed]  [Google Scholar]
61 Role of the cytopathologist in the management of thyroide nodule [Rôle du cytopathologiste dans la prise en charge dæun nodule thyroïdien]
Lassalle, S. and Hofman, V. and Butori, C. and Long, E. and Guevara, N. and Santini, J. and Brucker-Davies, F. and Sadoul, J.-L. and Hofman, P.
Revue Francophone des Laboratoires. 2008; 38(398): 37-44
[Pubmed]  [Google Scholar]
62 CytoJournal′s move to the new platform: More on financial model to the support open-access charter in cytopathology, publication quality indicators, and other issues
Shidham, V. and Pitman, M. and Demay, R. and Atkinson, B.
CytoJournal. 2008; 5(15)
[Pubmed]  [Google Scholar]
63 Molecular detection of PPARγ rearrangements and thyroid carcinoma in preoperative fine-needle aspiration biopsies
French, C.A. and Fletcher, J.A. and Cibas, E.S. and Caulfield, C. and Allard, P. and Kroll, T.G.
Endocrine Pathology. 2008; 19(3): 166-174
[Pubmed]  [Google Scholar]
64 Impact of molecular biology on the practice of cytopathology. How much information can be obtained from a few cells?
Srinivasan, R.
Bulletin, Postgraduate Institute of Medical Education and Research, Chandigarh. 2008; 42(4): 183-189
[Pubmed]  [Google Scholar]
65 Molecular Detection of PPAR? Rearrangements and Thyroid Carcinoma in Preoperative Fine-Needle Aspiration Biopsies
Christopher A. French,Jonathan A. Fletcher,Edmund S. Cibas,Christopher Caulfield,Paulette Allard,Todd G. Kroll
Endocrine Pathology. 2008; 19(3): 166
[Pubmed]  [Google Scholar] [DOI]
66 Recent developments in the clinical application of thyroid cancer biomarkers
Daniel Shibru,Ki-Wook Chung,Electron Kebebew
Current Opinion in Oncology. 2008; 20(1): 13
[Pubmed]  [Google Scholar] [DOI]
67 Genome-Wide Studies in Thyroid Neoplasia
Thomas J. Giordano
Endocrinology and Metabolism Clinics of North America. 2008; 37(2): 311
[Pubmed]  [Google Scholar] [DOI]
68 Rôle du cytopathologiste dans la prise en charge d’un nodule thyroïdien
Sandra Lassalle,Véronique Hofman,Catherine Butori,Elodie Long,Nicolas Guevara,José Santini,Françoise Brucker-Davies,Jean-Louis Sadoul,Paul Hofman
Revue Francophone des Laboratoires. 2008; 2008(398): 37
[Pubmed]  [Google Scholar] [DOI]
69 Clinical implications of BRAF mutation in thyroid carcinoma
Efisio Puxeddu,Cosimo Durante,Nicola Avenia,Sebastiano Filetti,Diego Russo
Trends in Endocrinology & Metabolism. 2008; 19(4): 138
[Pubmed]  [Google Scholar] [DOI]
70 Molecular Detection of PPAR$\gamma$ Rearrangements and Thyroid Carcinoma in Preoperative Fine-Needle Aspiration Biopsies
French, C.A. and Fletcher, J.A. and Cibas, E.S. and Caulfield, C. and Allard, P. and Kroll, T.G.
Endocrine pathology. 2008; 19(3): 166-174
[Pubmed]  [Google Scholar]
71 Recent developments in the clinical application of thyroid cancer biomarkers
Shibru, D., Chung, K.-W., Kebebew, E.
Current Opinion in Oncology. 2008; 20(1): 13-18
[Pubmed]  [Google Scholar]
72 CytoJournalæs move to the new platform: More on financial model to the support open-access charter in cytopathology, publication quality indicators, and other issues
Shidham, VB and Pitman, MB and DeMay, RM and Atkinson, BF
CytoJournal. 2008; 5(1): 15
[Pubmed]  [Google Scholar]
73 Clinical implications of BRAF mutation in thyroid carcinoma
Puxeddu, E. and Durante, C. and Avenia, N. and Filetti, S. and Russo, D.
Trends in Endocrinology \& Metabolism. 2008; 19(4): 138-145
[Pubmed]  [Google Scholar]
74 Update on the molecular diagnosis of endocrine tumors: toward-omics-based personalized healthcare?
Weber, F. and Eng, C.
Journal of Clinical Endocrinology \& Metabolism. 2008; 93(4): 1097-1104
[Pubmed]  [Google Scholar]
75 Cytological and molecular diagnosis of solid variant of papillary thyroid carcinoma: A case report
Troncone, G. and Russo, M. and Malapelle, U. and Accardo, M. and Ferraro, A. and Cozzolino, I. and Palombini, L.
CytoJournal. 2008; 5(1): 2
[Pubmed]  [Google Scholar]
76 Perspectives for improved and more accurate classification of thyroid epithelial tumors
Eszlinger, M. and Krohn, K. and Hauptmann, S. and Dralle, H. and Giordano, T.J. and Paschke, R.
Journal of Clinical Endocrinology \& Metabolism. 2008; 93(9): 3286-3294
[Pubmed]  [Google Scholar]
77 Tyrosine kinase activating mutations in human malignancies: Implications for diagnostic pathology
Holden, J.A., Willmore-Payne, C., Layfield, L.J.
Experimental and Molecular Pathology. 2008; 85(1): 68-75
[Pubmed]  [Google Scholar]
78 Genome-Wide Studies in Thyroid Neoplasia
Giordano, T.J.
Endocrinology and Metabolism Clinics of North America. 2008; 37(2): 311-331
[Pubmed]  [Google Scholar]
79 Detection of epidermal growth factor receptor gene mutations in cytology specimens from patients with non-small cell lung cancer utilising high-resolution melting amplicon analysis
Smith, G.D., Chadwick, B.E., Willmore-Payne, C., Bentz, J.S.
Journal of Clinical Pathology. 2008; 61(4): 487-493
[Pubmed]  [Google Scholar]
80 The best in CytoJournal: 2006
Cohen, M.B.
CytoJournal. 2007; 4(1): 12
[Pubmed]  [Google Scholar]
81 Tissue Harvester with Functional Valve(THFV): Shidhamæs device for reproducibly higher specimen yield by fine needle aspiration biopsy with easy to perform steps
Shidham, V.B. and Pandit, A.W. and Rao, R.N. and Basir, Z. and Shidham, A.
BMC Clinical Pathology. 2007; 7(1): 2
[Pubmed]  [Google Scholar]
82 Detection of EGFR gene mutations in cytology specimens from patients with non-small cell lung cancer utilizing high-resolution melting amplicon analysis
Smith, G.D. and Chadwick, B.E. and Willmore-Payne, C. and Bentz, J.S.
British Medical Journal. 2007;
[Pubmed]  [Google Scholar]
83 BRAF mutations in melanocytic lesions and papillary thyroid carcinoma samples identified using melting curve analysis of polymerase chain reaction products
Hay, R. and Erin MacRae, MBT and Barber, D. and Khalil, M. and Demetrick, D.J.
Archives of Pathology and Laboratory Medicine. 2007; 131(9): 1361-1367
[Pubmed]  [Google Scholar]
84 Perspectives and limitations of microarray-based gene expression profiling of thyroid tumors
Eszlinger, M. and Krohn, K. and Kukulska, A. and Jarzab, B. and Paschke, R.
Endocrine reviews. 2007; 28(3): 322
[Pubmed]  [Google Scholar]
85 Thank you reviewers-CytoJournal 2007
Shidham, V.B. and Atkinson, B.F.
CytoJournal. 2007; 4(1): 4
[Pubmed]  [Google Scholar]
86 BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications
Xing, M.
Endocrine reviews. 2007; 28(7): 742-762
[Pubmed]  [Google Scholar]
87 Detection of BRAF V600E activating mutation in papillary thyroid carcinoma using PCR with allele-specific fluorescent probe melting curve analysis
Rowe, L.R., Bentz, B.G., Bentz, J.S.
Journal of Clinical Pathology. 2007; 60(11): 1211-1215
[Pubmed]  [Google Scholar]
88 Tissue Harvester with Functional Valve (THFV): Shidhamæs device for reproducibly higher specimen yield by fine needle aspiration biopsy with easy to perform steps
Shidham, V.B. and Pandit, A.W. and Rao, R.N. and Basir, Z. and Shidham, A.
BMC Clinical Pathology. 2007; 7(2)
[Pubmed]  [Google Scholar]
89 Applications of molecular techniques to fine-needle aspiration biopsy
Savitri Krishnamurthy
Cancer. 2007; 111(2): 106
[HTML Full text]  [Google Scholar] [DOI]

 

  Site Map | Copyright and Disclaimer
© 2007 - CytoJournal | A journal by Cytopathology Foundation Inc with Wolters Kluwer - Medknow
New version online since 1st July '08
Open Access